Educational Initiatives Boost Women’s HIV Awareness, PrEP Uptake | IDWeek 2024
Three posters showcased at IDWeek 2024 focused on enhancing access to HIV prevention and treatment, as well as increasing uptake of pre-exposure prophylaxis (PrEP) among women.
Despite advancements in HIV prevention and treatment, disparities persist in accessing sexual health services, particularly for women. Three posters presented at IDWeek 2024 highlighted the critical role of educational initiatives in increasing women’s awareness of pre-exposure prophylaxis (PrEP) and facilitating access to HIV testing services.
READ MORE: Women's Health Resource Center
Check out more of our IDWeek coverage here.
Don’t get left behind: Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips delivered straight to your inbox.
References
1. Sheth AN, Vincent SY, Simone L, et al. Impact of tailored education on engagement in sexual health and HIV prevention services among US women. Presented at: IDWeek 2024; October 16-19, 2024; Los Angeles, CA. Poster P-523.
2. Poteat T, Sarkar S, Ragone L, et al. Opportunities for PrEP awareness and engagement: A survey among healthcare-seeking cisgender women in the US. Presented at: IDWeek 2024; October 16-19, 2024; Los Angeles, CA. Poster P-528.
3. Short WR, Patel P, Verdier G, et al. Extrapolating expected efficacy, safety, and pharmacokinetics (PK) of dolutegravir/lamivudine (DTG.3TC) in pregnant people living with HIV-1 from pregnancy data with combination DTG and/or 3TC antiretroviral therapies. Presented at: IDWeek 2024; October 16-19, 2024; Los Angeles, CA. Poster P-574.
Patient Outcomes, Holistic Care Hinges on Evolving Role of Pharmacist | Asembia 2025
Published: April 29th 2025 | Updated: April 29th 2025From medication dispensers to comprehensive patient care advocates, pharmacists have never been more essential to the health care team and to patients in specialty care.
